Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction

BI Coculescu, GV Dincă, C Bălăeţ… - Journal of Enzyme …, 2018 - Taylor & Francis
The current study was conducted on a sample of 91 patients diagnosed with diastolic
dysfunction (DD) with preserved systolic function caused by a painful chronic ischaemic …

[PDF][PDF] Serum concentration of hsCRP-possible marker for therapy evaluation in left ventricular dysfunction with preserved ejection fraction

BI Coculescu, GV Dinca, G Manole… - Rev. Chim …, 2018 - academia.edu
The study on a subset of 208 patients with diastolic dysfunction with the ejection fraction
preserved discusses the possibility of circulating CRP levels to be accepted as a diagnostic …

[PDF][PDF] The possible serum complex-biomarkers for the early diagnosis of diastolic dysfunction with preserved systolic function

BI Coculescu, G Manole, AL Dinca… - Rev Chim …, 2019 - pdfs.semanticscholar.org
1Titu Maiorescu University Bucharest, Faculty of Medicine, 22 Dambovnicului, 040441,
Bucharest, Romania 2Specialist doctor, Medicover Hospital Bucharest, 24 Preciziei …

[PDF][PDF] PON-1, possible biomarker for diagnosis but also for risk in diastolic dysfunction with preserved ejection fraction

BI Coculescu, T Harsovescu, IS Tudorache… - Rev Chim …, 2019 - researchgate.net
The determined values of paraoxonase-1 serum concentration in 91 patients with cardiac
insufficiency with a preserved ejection fraction with etiology of ischemic cardiopathy showed …

[PDF][PDF] Growth differential factor 15 (GDF-15), possible biomarker in heart failure

VG Dinca, G Manole, D Cochior, AL Dinca - Rev. Chim.(Bucharest), 2017 - academia.edu
The present study aims at determining on the one hand the growth differentiation factor 15
significance as possible risk biomarker for this condition and, on the other hand, the degree …

[PDF][PDF] Myeloperoxidase (MPO), possible biomarker in heart failure

SI Tudorache, BI Coculescu, G Manole… - Rev. de Chimie …, 2019 - academia.edu
The justification for choosing and this enzyme marker to investigate the variation in serum
concentration is supported by at least two arguments: cytokine myeloperoxidase at the level …

[PDF][PDF] Preserving fertility in ovarian cancer

AL Dinca, VG Dinca, RD Birla… - Rev. Chim.(Bucharest …, 2019 - academia.edu
In the last decades, by improving the oncological treatment, the life expectancy of the
adolescent patients with ovarian cancer has been increased and more than that they have …

[PDF][PDF] Screening in ovarian neoplasm

AL Dinca, VG Dinca, SM Constantinoiu, RD Birla - cancer, 2016 - revistadechimie.ro
Ovarian neoplasm is extremely aggressive and has a high mortality rate among affected
women; therefore, the crucial role of screening tests is easy to understand. Prevention and …